[ARWR] YoY Quarter Result on 31-Mar-2019 [#Q2]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q2]
Profit Trend
QoQ- 98.53%
YoY- 260.55%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 151,805 32,811 23,529 48,148 650 8,986 44 288.48%
PBT 44,366 -26,818 -19,836 23,897 -14,884 -6,043 -20,816 -
Tax -2,813 -1,524 0 -0 -150 -81 -449 35.75%
NP 44,366 -26,818 -19,836 23,897 -14,884 -6,043 -20,816 -
Tax Rate 6.34% - - 0.00% - - - -
Total Cost 107,439 59,629 43,364 24,251 15,534 15,028 20,860 31.39%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 29.23 -81.73 -84.30 49.63 -2,289.45 -67.24 -47,579.11 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS 0.42 -0.26 -0.20 0.25 -0.18 -0.08 -0.35 -
EPS Diluted 0.41 -0.26 -0.20 0.24 -0.18 -0.08 -0.35 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.